Semnur Pharmaceuticals, Inc. Investment Income, Interest
Semnur Pharmaceuticals, Inc. (SMNR) reported Investment Income, Interest of $18.08 thousand for the 3-month period ending 2025-06-30, per its 10-Q filed 2025-08-15.
Financial Statements › Income Statement › Other Income
us-gaap:InvestmentIncomeInterest · last filed 2025-08-15
- Semnur Pharmaceuticals, Inc. investment income, interest for the quarter ending 2025-06-30 was $18.08K, a 97.18% decline year-over-year.
- Semnur Pharmaceuticals, Inc. investment income, interest for the quarter ending 2025-03-31 was $78.97K, a 87.92% decline year-over-year.
- Semnur Pharmaceuticals, Inc. investment income, interest for the quarter ending 2024-12-31 was $86.72K, a 88.49% decline year-over-year.
- Semnur Pharmaceuticals, Inc. investment income, interest for the quarter ending 2024-09-30 was $197.28K, a 82.86% decline year-over-year.
- Semnur Pharmaceuticals, Inc. investment income, interest for fiscal 2024 was $1.58M, a 58.94% decline from fiscal 2023.
- Semnur Pharmaceuticals, Inc. investment income, interest for fiscal 2023 was $3.84M, a 214.61% increase from fiscal 2022.
- Semnur Pharmaceuticals, Inc. investment income, interest for fiscal 2022 was $1.22M.
| Period end | Investment Income, Interest 3 month | Investment Income, Interest 6 month | Investment Income, Interest 9 month | Investment Income, Interest 12 month |
|---|---|---|---|---|
| 2025-06-30 | $18.08K 10-Q · filed 2025-08-15 | $97.05K 10-Q · filed 2025-08-15 | $183.77K derived: sum of 3 quarters · filed 2025-08-15 | $381.05K derived: sum of 4 quarters · filed 2025-08-15 |
| 2025-03-31 | $78.97K 10-Q · filed 2025-05-16 | $165.69K derived: sum of 2 quarters · filed 2025-05-16 | $362.97K derived: sum of 3 quarters · filed 2025-05-16 | $1.00M derived: sum of 4 quarters · filed 2025-08-15 |
| 2024-12-31 | $86.72K derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-02 | $284.00K derived: sum of 2 quarters · filed 2025-04-02 | $924.16K derived: sum of 3 quarters · filed 2025-08-15 | $1.58M 10-K · filed 2025-04-02 |
| 2024-09-30 | $197.28K 10-Q · filed 2024-11-19 | $837.43K derived: sum of 2 quarters · filed 2025-08-15 | $1.49M 10-Q · filed 2024-11-19 | $2.24M derived: sum of 4 quarters · filed 2025-08-15 |
| 2024-06-30 | $640.16K 10-Q · filed 2025-08-15 | $1.29M 10-Q · filed 2025-08-15 | $2.05M derived: sum of 3 quarters · filed 2025-08-15 | $3.20M derived: sum of 4 quarters · filed 2025-08-15 |
| 2024-03-31 | $653.88K 10-Q · filed 2025-05-16 | $1.41M derived: sum of 2 quarters · filed 2025-05-16 | $2.56M derived: sum of 3 quarters · filed 2025-05-16 | $3.58M derived: sum of 4 quarters · filed 2025-05-16 |
| 2023-12-31 | $753.54K derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-02 | $1.90M derived: sum of 2 quarters · filed 2025-04-02 | $2.93M derived: sum of 3 quarters · filed 2025-04-02 | $3.84M 10-K · filed 2025-04-02 |
| 2023-09-30 | $1.15M 10-Q · filed 2024-11-19 | $2.18M derived: sum of 2 quarters · filed 2024-11-19 | $3.09M 10-Q · filed 2024-11-19 | $3.82M derived: sum of 4 quarters · filed 2024-11-19 |
| 2023-06-30 | $1.03M 10-Q · filed 2024-08-19 | $1.94M 10-Q · filed 2024-08-19 | $2.66M derived: sum of 3 quarters · filed 2024-08-19 | $3.05M derived: sum of 4 quarters · filed 2024-08-19 |
| 2023-03-31 | $912.65K 10-Q · filed 2024-05-22 | $1.64M derived: sum of 2 quarters · filed 2024-05-22 | $2.02M derived: sum of 3 quarters · filed 2024-05-22 | $2.13M derived: sum of 4 quarters · filed 2024-05-22 |
| 2022-12-31 | $726.34K derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | $1.11M derived: sum of 2 quarters · filed 2024-04-01 | $1.22M derived: sum of 3 quarters · filed 2024-04-01 | $1.22M 10-K · filed 2024-04-01 |
| 2022-09-30 | $380.43K 10-Q · filed 2023-11-09 | $495.26K derived: sum of 2 quarters · filed 2023-11-09 | $495.26K 10-Q · filed 2023-11-09 | |
| 2022-06-30 | $114.83K 10-Q · filed 2023-08-15 | $114.83K 10-Q · filed 2023-08-15 | ||
| 2022-03-31 | $0.00 10-Q · filed 2023-05-15 |